NewsHKSubscribe
Markets市場

Kymera Therapeutics faces shareholder probe over director fiduciary duties

Shareholder litigation has become a steady current in U.S.-listed biotech, tracking a sector where capital is scarce and governance scrutiny has tightened. New York law firm Purcell & Lefkowitz LLP announced on July 16, 2026,…

By Vincent Lorne·July 16, 2026·二〇二六年七月十六日·2 min read

Source · 來源

prnewswire.com

Share · 分享
Xinfw
← Back to the News DeskFiled · Markets

Related Dispatches

相關報導
News Desk →
  1. 01Markets市場

    Nvidia lifts AI infrastructure stocks as most Magnificent Seven slip in premarket

    The capex cycle running through AI infrastructure pulled sharply away from the broader technology complex in premarket trading,…

    August 27, 2026 · 2 min

  2. 02Markets市場

    Wall Street falls after inflation data, Nvidia earnings next in view

    Fresh inflation figures steered Wall Street indices lower as investors repositioned ahead of the upcoming earnings report from…

    August 26, 2026 · 2 min

  3. 03Markets市場

    SK Hynix shares surge over 12% in Seoul on massive buyback announcement

    Seoul's equity session turned sharply higher on news of a massive stock buyback from SK Hynix. Shares in the South Korean…

    August 20, 2026 · 2 min

Elsewhere on the Desk

All Dispatches →
Crypto加密

Charles Schwab Expands Crypto Platform With Solana, Avalanche, and Chainlink

August 27, 2026 · 2 min

Crypto加密

UK tax data counts 240 crypto millionaires for the 2024-25 fiscal year

August 27, 2026 · 2 min

Earnings

Nvidia's 70% growth forecast puts it on track to become tech's No. 2 company by revenue

August 27, 2026 · 2 min

Deals

Greenlight Capital sees Primo Brands free cash flow gap as merger dust settles

August 27, 2026 · 2 min